Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Naoki Hayama"'
Autor:
Yoshitaka Ono, Naoki Hayama, Shigeaki Hattori, Yoko Ito, Tsuyoshi Oguma, Fumio Sakamaki, Koichiro Asano
Publikováno v:
Thoracic Cancer, Vol 13, Iss 24, Pp 3504-3509 (2022)
Abstract Background Febrile neutropenia (FN) during cancer chemotherapy can lead to morbidity and mortality. The Multinational Association of Supportive Care in Cancer (MASCC) and clinical index of stable febrile neutropenia (CISNE) scores have been
Externí odkaz:
https://doaj.org/article/e22ee558aa294d0188ae602634a3cc6b
Autor:
Yoko Ito, Tsuyoshi Oguma, Noriko Nakamura, Yukihiro Horio, Takahisa Takihara, Fuminari Takahashi, Keito Enokida, Jun Tanaka, Katsuyoshi Tomomatsu, Kyoko Niimi, Sakurako Tajiri, Naoki Hayama, Koichiro Asano
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Objectives To analyse the clinical characteristics and prognosis of acute exacerbation (AE) in patients with idiopathic pulmonary fibrosis (IPF) and pulmonary emphysema.Design A multicentre retrospective cohort studySetting Two university hospitals i
Externí odkaz:
https://doaj.org/article/dba15cad4d264dcfa09d7294dbcb7a37
Autor:
Takuya Aoki, Takeshi Akiba, Jun Nishiyama, Sakurako Tajiri, Naoki Hayama, Genki Takahashi, Jun Tanaka, Masako Sato, Hiroto Takiguchi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Takahisa Takihara, Kyoko Niimi, Tsuyoshi Oguma, Mitsutomo Kohno, Ryota Masuda, Tetsuya Urano, Hitoshi Itoh, Hiroshi Kajiwara, Naoya Nakamura, Etsuo Kunieda, Mitsunori Matsumae, Masayuki Iwazaki, Koichiro Asano
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-16 (2019)
Abstract Background Although development of immune checkpoint inhibitors and various molecular target agents has extended overall survival time (OS) in advanced non-small cell lung cancer (NSCLC), a complete cure remains rare. We aimed to identify fe
Externí odkaz:
https://doaj.org/article/aceb80a7728c4724bab97a6e4d239c59
Autor:
Yoshitaka Ono, Shohei Obayashi, Yukihiro Horio, Kyoko Niimi, Naoki Hayama, Yoko Ito, Tsuyoshi Oguma, Koichiro Asano
Publikováno v:
Allergology International, Vol 70, Iss 1, Pp 129-130 (2021)
Externí odkaz:
https://doaj.org/article/99479716b4e94a61b89090db156b7071
Autor:
Hiroto Takiguchi, Tomoe Takeuchi, Kyoko Niimi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Naoki Hayama, Tsuyoshi Oguma, Takuya Aoki, Tetsuya Urano, Satomi Asai, Hayato Miyachi, Koichiro Asano
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196132 (2018)
Chronic obstructive pulmonary disease (COPD) mainly develops after long-term exposure to cigarette or biomass fuel smoke, but also occurs in non-smokers with or without a history of asthma. We investigated the proportion and clinical characteristics
Externí odkaz:
https://doaj.org/article/77fe0bf8c9cd4a669ab4028434f5dcfd
Autor:
Tsuyoshi Oguma, Takashi Nagaoka, Muneshige Kurahashi, Naofumi Kobayashi, Shinji Yamamori, Chizuko Tsuji, Hiroto Takiguchi, Kyoko Niimi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Naoki Hayama, Takuya Aoki, Tetsuya Urano, Kazushige Magatani, Sunao Takeda, Tadashi Abe, Koichiro Asano
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0174802 (2017)
BACKGROUND:Exhaled volatile organic compounds (VOC) are being considered as biomarkers for various lungs diseases, including cancer. However, the accurate measurement of extremely low concentrations of VOC in expired air is technically challenging. W
Externí odkaz:
https://doaj.org/article/bfc5cf801b944551a420a6d10cffe895
Autor:
Mika URATA, Yoko ITO, Daisuke OGIYA, Naokata KUTSUZAWA, Go OGURA, Mitsuharu UEDA, Naoki HAYAMA, Tsuyoshi OGUMA, Koichiro ASANO
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Apr2024, Vol. 49 Issue 1, p12-16, 5p
Autor:
Ayane, Torii, Yoshitaka, Ono, Shohei, Obayashi, Asako, Kitahara, Kana, Oshinden, Yukihiro, Horio, Kyoko, Niimi, Naoki, Hayama, Tsuyoshi, Oguma, Kazuhito, Hatanaka, Koichiro, Asano, Yoko, Ito
Publikováno v:
Internal Medicine. 61:2649-2653
Cryptogenic bilateral fibrosing pleuritis is a rare condition, and its pathogenesis and clinical course are poorly understood, with no established therapy available. A 61-year-old man presented with bilateral pleural thickening and lymphocytic exudat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206cdbc0d3b7fe817a95c06d2af4228e
https://doi.org/10.2169/internalmedicine.8758-21
https://doi.org/10.2169/internalmedicine.8758-21
Autor:
Eriko OKAZAKI, Shigeaki HATTORI, Katsuyoshi TOMOMATSU, Shingo IIJIMA, Kohei UMEMOTO, Kai YAMAZAKI, Yukihiro HORIO, Naoki HAYAMA, Yoko ITO, Tsuyoshi OGUMA, Koichiro ASANO
Publikováno v:
Tokai Journal of Experimental & Clinical Medicine; Apr2024, Vol. 49 Issue 1, p9-11, 3p
Autor:
Koichiro Asano, Jun Tanaka, Kyoko Niimi, Tsuyoshi Oguma, Shohei Obayashi, Katsuyoshi Tomomatsu, Naoki Hayama, Mika Urata, Yoko Ito
Publikováno v:
Internal Medicine. 61:1577-1580
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are common therapeutic agents for EGFR mutation-positive advanced non-small-cell lung cancer. There has been no report of rhabdomyolysis caused by an overdose of EGFR-TKIs. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f5a4515dfe0c44a7b0e4680047460a
https://doi.org/10.2169/internalmedicine.8168-21
https://doi.org/10.2169/internalmedicine.8168-21